TY - JOUR AU - Pathak, Mallika AU - Ojha, Himanshu AU - Tiwari, Anjani K. AU - Sharma, Deepti AU - Saini, Manisha AU - Kakkar, Rita PY - 2017 DA - 2017/12/19 TI - Design, synthesis and biological evaluation of antimalarial activity of new derivatives of 2,4,6-s-triazine JO - Chemistry Central Journal SP - 132 VL - 11 IS - 1 AB - Dihydrofolate reductase (DHFR) is an important enzyme for de novo synthesis of nucleotides in Plasmodium falciparum and it is essential for cell proliferation. DHFR is a well known antimalarial target for drugs like cycloguanil and pyrimethamine which target its inhibition for their pharmacological actions. However, the clinical efficacies of these antimalarial drugs have been compromising due to multiple mutations occurring in DHFR that lead to drug resistance. In this background, we have designed 22 s-triazine compounds using the best five parameters based 3D-QSAR model built by using genetic function approximation. In-silico designed compounds were further filtered to 6 compounds based upon their ADME properties, docking studies and predicted minimum inhibitory concentrations (MIC). Out of 6 compounds, 3 compounds were synthesized in good yield over 95% and characterized using IR, 1HNMR, 13CNMR and mass spectroscopic techniques. Parasitemia inhibition assay was used to evaluate the antimalarial activity of s-triazine compounds against 3D7 strain of P. falciparum. All the three compounds (7, 13 and 18) showed 30 times higher potency than cycloguanil (standard drug). It was observed that compound 18 was the most active while the compound 13 was the least active. On the closer inspection of physicochemical properties and SAR, it was observed that the presence of electron donating groups, number of hydrogen bond formation, lipophilicity of ligands and coulson charge of nitrogen atom present in the triazine ring enhances the DHFR inhibition significantly. This study will contribute to further endeavours of more potent DHFR inhibitors. SN - 1752-153X UR - https://doi.org/10.1186/s13065-017-0362-5 DO - 10.1186/s13065-017-0362-5 ID - Pathak2017 ER -